Herz

Article	Citations
SARS-CoV-2: a potential novel etiology of fulminant myocarditis	259
Ventilation of COVID-19 patients in intensive care units	73
ESC 2019 guidelines for the diagnosis and management of chronic coronary syndromes	51
Arrhythmias and sudden cardiac death in the COVID-19 pandemic	28
Takotsubo syndrome: between evidence, myths, and misunderstandings	27
Heart and brain interactions	24
A simple formula to predict echocardiographic diastolic dysfunction—electrocardiographic diastolic index	23
SARS-CoV-2 as potential cause of cardiac inflammation and heart failure. Is it the virus, hyperinflammation, or MODS?	19
Vagal stimulation in heart failure	18
Common genetic predisposition for heart failure and cancer	16
Emerging role of immune checkpoint inhibitors and their relevance for the cardiovascular system	16
Evaluation of the relationship between COVID-19 pneumonia severity and pulmonary artery diameter measurement	16
Inflammatory dilated cardiomyopathy	16
Myocardial involvement in coronavirus disease 19	14
The future of heart failure with preserved ejection fraction	12
Characteristics of COVID-19 pandemic and public health consequences	12
Echocardiography and biomarkers for the diagnosis of cardiotoxicity	11
Drug-coated balloon versus drug-eluting stent for treating de novo coronary lesions in large vessels: a meta-analysis of clinical trials	11
German chest pain unit registry: data review after the first decade of certification	11
Gender and career in cardiology—a cross-sectional study	10
Inhibitors of the renin–angiotensin system and SARS-CoV-2 infection	10
Oncocardiology: new challenges, new opportunities	10
Genetic association between eNOS gene polymorphisms and risk of carotid atherosclerosis	10
Role of iron homeostasis in the heart	10
Comorbidities in heart failure with preserved ejection fraction	10

Valvular heart disease in patients with chronic kidney disease	10
Biomarkers for infarct diagnosis and rapid rule-out/rule-in of acute myocardial infarction	10
Werden die Karten der CT-Koronarangiographie mit der FFRCT neu gemischt?	9
Medikamentöse Sekundärprävention bei Patienten mit peripherer arterieller Verschlusskrankheit	9
Luftverschmutzung und Herz-Kreislauf-Erkrankungen	8
Role of IL-9, IL-2RA, and IL-2RB genetic polymorphisms in coronary heart disease	8
Clinical review of sick sinus syndrome and atrial fibrillation	7
ESC-Leitlinien 2020 zum Vorhofflimmern	7
ESC-Leitlinie 2020 zur Behandlung von Erwachsenen mit angeborenem Herzfehler (ACHD)	7
Atrial remodeling and atrial fibrillation recurrence after catheter ablation	7
Mapping atrial fibrillation	7
Reduced rate of admissions for acute coronary syndromes during the COVID-19 pandemic: an observational analysis from a tertiary hospital in Germany	6
Management of cardiovascular diseases in patients with diabetes	6
ESC-Leitlinie 2020: akutes Koronarsyndrom ohne persistierende ST-Strecken-Hebungen	6
COVID-19—What we know and what we need to know: There are more questions than answers	6
Vergleich der Ergebnisse zwischen langem Einzelstent und überlappenden Stents: Metaanalyse der Literatur	6
Herzinsuffizienzleitlinien 2021 der ESC	6
ESC-Leitlinie Sportkardiologie 2020	5
Outcomes of patients with ST-segment myocardial infarction admitted during the COVID-19 pandemic	5
Protecting patients and healthcare personnel from COVID-19: considerations for practice and outpatient care in cardiology	5
The COVID-19 pandemic in China: from dynamic zero-COVID to current policy	5
Value of microalbuminuria in the diagnosis of heart failure with preserved ejection fraction	5
Klinische Bedeutung der 4. Universellen Definition des Myokardinfarkts	5
Mind and body interventions in cardiology	5
Current devices and interventions in mitral regurgitation	5
COVID-19-Pandemie	5
Die ESC zu COVID-19 – keine Leitlinie, aber ein lernender Leitfaden	4
Effects of SARS-CoV-2 and its functional receptor ACE2 on the cardiovascular system	4
ERC-Leitlinien 2021 zur kardiopulmonalen Reanimation	4
Postcardiac injury syndrome after cardiac implantable electronic device implantation	4
ESC-Leitlinie 2022 onkologische Kardiologie	4
Associations between genetic variations in microRNA and myocardial infarction susceptibility: a meta-analysis and systematic review	4
After ISCHEMIA: Is coronary CTA the new gatekeeper?	4
2022 ESC/ERS-Leitlinien zur Diagnostik und Therapie der pulmonalen Hypertonie	4
Current status of antithrombotic therapy and in-hospital outcomes in patients with atrial fibrillation undergoing percutaneous coronary intervention in Germany	4
Heart failure with preserved ejection fraction, atrial fibrillation, and increased NT‑proBNP levels	3
Schätzungen der Übersterblichkeit während der COVID-19-Pandemie hängen stark von subjektiven methodischen Entscheidungen ab	3
Obesity paradox in pulmonary hypertension due to left ventricular systolic dysfunction	3
Surgical vs. drug therapy in patients with patent foramen ovale and cryptogenic stroke	3
The COVID-19 Registry in Rhineland-Palatinate in the context of international registry activities documenting COVID-19 outcomes	3
Prognostic value of fragmented QRS complex in patients with acute myocardial infarction	3
Troponinerhöhung beim akuten ischämischen Schlaganfall – unspezifisch oder Ausdruck eines akuten Myokardinfarkts?	3
New therapeutic approaches for the treatment of hypertriglyceridemia	3
Favorable electrocardiographic changes after substantial weight loss in patients with morbid obesity	3
Grundlagen der Angiologie bei peripherer arterieller Verschlusskrankheit (pAVK)	3
Zusammenhang zwischen myokardialem Bridging und letalen ventrikulären Arrhythmien bei Patienten mit hypertropher Kardiomyopathie: die HCM-MB-Studie	3
Arrhythmogenic right ventricular cardiomyopathy	3
Lärmbelästigung in der deutschen Allgemeinbevölkerung	3
Neglected cardiovascular diseases and their significance in the Global North	3
Infarktbedingter kardiogener Schock	3

Cardiovascular emergencies in the COVID-19 pandemic	3
Risk stratification for sudden cardiac death in patients with heart failure	3
Extracorporeal membrane oxygenation in the treatment of respiratory failure during COVID‑19	3
ESC-Leitlinien 2021 zur Schrittmacher- und Resynchronisationstherapie	3
Neue ESC-Leitlinien 2021 zur Prävention von kardiovaskulären Erkrankungen	3
Transcatheter therapies for severe tricuspid regurgitation. Quo vadis?	3
Effect of Ginkgo biloba extract on pacemaker channels encoded by HCN gene	3
Influence of ablation index on the incidence of cardiac tamponade complicating pulmonary vein isolation	3
Diagnostik und Therapie der Lungenembolie	3
Diagnostic role of echocardiography for patients with heart failure symptoms and preserved left ventricular ejection fraction	3
Impact of atrial flow regulator (AFR) implantation on 12-month mortality in heart failure	3
Akuter Myokardinfarkt – aktuelle Aspekte	3
Clinical significance of glycated hemoglobin in acute coronary syndrome patients from the CCC-ACS project	3
Sex differences in cardiovascular risk factors for myocardial infarction	3
Catheter-directed therapy in pulmonary embolism	3
Patent foramen ovale—When to close and how?	3
Left atrial volume index and pulmonary arterial pressure predicted MACE among patients with STEMI during 8-year follow-up: experience from a tertiary center	3
Digital health solutions in the screening of subclinical atrial fibrillation	3
Endocardial left ventricular pacing	3
Echocardiographic assessment in cardiogenic shock	2
Prognostic value of DCTA scoring system in heart failure	2
Left ventricular systolic dysfunction in patients with unprotected left main coronary artery disease	2
Incidence of permanent pacemaker implantation after valve replacement surgery	2
Correlation between decreased plasma miR-29a and vascular endothelial injury induced by hyperlipidemia	2
Vergleich von Chest Pain Units und Stroke Units	2
Non-transvenous ICD therapy: current status and beyond	2
Optimal antiplatelet and anticoagulation strategies in acute coronary syndromes	2
Poor recovery of cardiac function in myocardial infarction patients with metabolic syndrome and microalbuminuria	2
Rhythmologische und metabolische Kontrolle	2
Survey of clinical practice pattern in Germany’s certified chest pain units	2
Die neue ESC-Leitlinie zum Management ventrikulärer Tachyarrhythmien	2
Nachsorge nach kathetergestütztem perkutanen Aortenklappenersatz (TAVI)	2
Heart failure in advanced chronic kidney disease: treatment rationale	2
Umweltfaktoren und ihre Auswirkungen auf die COVID-19-Pandemie	2
Herz-Kreislauf-Erkrankungen und COVID-19	2
Lipoproteinapherese	2
Personalisierte Behandlungskonzepte bei arterieller Hypertonie	2
Prävention des plötzlichen Herztods	2
Treating patients with excessively large annuli with self-expanding transcatheter aortic valves: insights into supra-annular structures that anchor the prosthesis	2
Zusammenhang zwischen Plättchenmassenindex und postoperativem Vorhofflimmern nach elektiver Koronararterienbypassoperation: eine retrospektive Studie	2
Evaluation of thrombolytic treatment effect on frontal plane QRS-T angle in patients with acute pulmonary embolism	2
Management strategies in heart failure with preserved ejection fraction	2
Establishing an oncocardiology service	2
Serum heparanase levels and left atrial/left atrial appendage thrombus in patients with nonvalvular atrial fibrillation	2
Gesättigte Fettsäuren und kardiovaskuläres Risiko	2
Peripoperative Mortalität nach ICD-Implantation	2
Assessment of proarrhythmic ventricular electrophysiological remodeling in patients with rheumatoid arthritis	2
Is coronary artery tortuosity a predisposing factor for drug-eluting stent restenosis?	2
Statinintoleranz und statinassoziierte Muskelschmerzen	2
Association of CHA2DS2-VASc score with thrombus burden in patients with acute myocardial infarction undergoing SVG-PCI	2
Cardiac amyloidosis—interdisciplinary approach to diagnosis and therapy	2
Prevention and treatment of venous thromboembolism in cancer patients	2
Nitrates and risk of vasovagal reaction in femoral sheath removal after percutaneous intervention	2
Association between MTHFR C677T polymorphism and risk of coronary artery disease in the Chinese population: meta-analysis	2
Revascularization in cardiogenic shock	2
Myocarditis in the era of SARS-CoV-2: one piece of a complex puzzle?	2
Aorten- und Herzklappenerkrankungen, Kardiomyopathien und Herzinsuffizienz in der Schwangerschaft	2
Kanadas Leitlinienempfehlung zu Alkohol und Gesundheit	1
Herzinsuffizienz mit erhaltener Ejektionsfraktion (HFpEF)	1
Effects of TCFA on stent neointimal coverage at 9 months after EXCEL drug-eluting stent implantation assessed by OCT	1
Aktuelle Technologien zur interventionellen Therapie der Trikuspidalklappeninsuffizienz	1
Neuer Standard: Kombinationstherapie zur Behandlung von Fettstoffwechselstörungen	1
Transvenous extraction of pacemaker leads via femoral approach using a gooseneck snare	1
Aortenstenose – welche diagnostischen Algorithmen und welche Therapie?	1
Prognostischer Wert der erweiterten kardialen Risikobeurteilung vor elektiver offener Bauchaortenchirurgie	1
First experiences with a new balloon-expandable Myval transcatheter aortic valve: a preliminary study	1
Impact of postdischarge care fragmentation on clinical outcomes and survival following transcatheter aortic valve replacement	1
White thrombi on optical coherence tomography after rotational atherectomy of severely calcified coronary lesions	1
Management des akuten Koronarsyndroms ohne ST-Strecken-Hebung	1
Diagnose und Behandlung der kardialen Amyloidose	1
Hypertrophe Kardiomyopathie	1
Predictors of adequate intraprocedural premature ventricular complex (PVC) frequency during idiopathic PVC ablation	1
Cardiovascular disease in patients with chronic kidney disease	1
Association of T66A polymorphism in CASQ2 with PR interval in a Chinese population	1
Radial access first for PCI in acute coronary syndrome	1
Pulmonary hypertension associated with left heart disease	1
Haarkortisol als chronischer Stressparameter bei Patienten mit akutem ST-Strecken-Hebungs-Infarkt	1
Treatment of heart failure with preserved ejection fraction with SGLT2 inhibitors: new therapy standard?	1
Serum osteoprotegerin level is independently related to subclinical left atrial mechanical function in patients with hypertension and diabetes	1
After ISCHEMIA: Is cardiac MRI a reliable gatekeeper for invasive angiography and myocardial revascularization?	1

Evaluation of atrial fibrillation risk in patients with vasovagal syncope	1
Schutz von Gesundheitspersonal und Patienten über 3 Jahre COVID-19	1
Catheter ablation for atrial fibrillation: impact on mortality, morbidity, quality of life, and implications for the future	1
After ISCHEMIA: is invasive physiology the only remaining gatekeeper for myocardial revascularization in chronic coronary syndromes?	1
Pulmonary hypertension due to left heart disease with pulmonary arterial wedge pressure ≤15 mm Hg	1
RAAS-Hemmung und darüber hinaus – Herz-Kreislauf-Medikation bei Patienten mit einem Risiko für oder Erkrankung durch COVID-19	1
Effects of oral colchicine administration as first-line adjunct therapy in myopericarditis	1
Cardiorenal benefits of mineralocorticoid antagonists in CKD and type 2 diabetes	1
Ultraschalluntersuchung der A. carotis zur verbesserten Vorhersage kardiovaskulärer Ereignisse und der Wirkung einer Statinbehandlung bei fortgeschrittener Atherosklerose	1
Outcomes after transcatheter aortic valve replacement in older patients	1
Sub-pocket small-hole drainage for pocket hematoma after cardiac device implantation	1
Outcomes of anatomical vs. functional testing for coronary artery disease	1
Pushing the limits for interventional treatment of aortic valve stenosis	1
Safety and feasibility of same-day discharge following catheter ablation of atrial fibrillation: what is known and what needs to be explored?	1
Impact of residual coronary artery disease on left ventricular function after percutaneous coronary intervention: a two-dimensional strain echocardiography study	1
Übersicht über Pharmakotherapie auf der Basis von ACE-2 bei COVID-19-Erkrankung: aktuelle Herausforderungen und zukünftige Entwicklungen	1
Diabetes, heart failure, and myocardial revascularization: Is there a new message from the ISCHEMIA trial?	1
Herzinsuffizienz: Leitlinien-Update der ESC 2023	1
Eine Mischung aus Aminophyllin und Heparin plus Nitroglycerin kann Bradykardie während Rotations-Atherektomie der A. coronaria dextra und des dominanten Ramus circumflexus vermindern	1
ESC-Leitlinien 2020 im Schatten der COVID-19-Pandemie	1
ESC guidelines 2023 on the management of endocarditis	1
Cardiac, possible cardiac, and likely non-cardiac origin of chest pain	1
Initial resolution of the COVID-19 pandemic in China—can the virus return?	1
Sekundärprävention nach TIA oder ischämischem Schlaganfall	1
Supraventricular arrhythmia in mitral valve prolapse	1
Wirkung von Training verschiedener Intensität auf die Herz-Lungen-Funktion und Lebensqualität von Patienten mit chronischer Herzinsuffizienz	1
Pulmonalvenenisolation bei Vorhofflimmern mittels „pulsed field ablation“	1
Zukunft der interventionellen Kardiologie	1
Prevalence of atrial fibrillation	1
Unexpected high level of severe events even in low-risk profile chest pain unit patients	1
“Virtual” heart team through a secure instant messenger smartphone app	1
Treatment rationale for coronary heart disease in advanced CKD	1
A practical approach for the treatment of post-COVID symptoms	1
Speckle tracking echocardiography in severe patient–prosthesis mismatch	1
Bifurkationsläsionen	1
Refined risk stratification, current treatment, and new therapeutic approaches in pulmonary arterial hypertension	1
Modified SAMe-TT2R2 score for predicting the therapeutic range of digoxin	1
Computertomographie zur periinterventionellen Diagnostik der Transkatheter-Aortenklappenimplantation	1